Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology
Description
No abstract
PubMed COVID-19 Clinical Care
4271 - 4280 of 4405 results found
Potential therapeutic value of necroptosis inhibitor for the treatment of COVID-19
Description
No abstract
Partners in crime: Autoantibodies complicit in COVID-19 pathogenesis
Description
No abstract
Pandemic Rule-Breakers, Moral Luck, and Blaming the Blameworthy
Description
No abstract
Potential Of Angiotensin-(1-7) In Covid-19 Treatment
Description
The new coronavirus currently named SARS-CoV-2 was announced by the World Health Organization as the virus causing the COVID-19 pandemic. The pathogenesis of SARS-CoV-2 initiates upon contact of a structural spike protein with the angiotensin II
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferrets
Description
Despite the continued spread of SARS-CoV-2 and emergence of variants of concern (VOC) that are capable of escaping preexisting immunity, therapeutic options are underutilized. In addition to preventing severe disease in high-risk patients, antivirals
Psychotherapy and Follow-Up in Health Care Workers After the COVID-19 Epidemic: A Single Center's Experience [Retraction]
Description
[This retracts the article DOI: 10.2147/PRBM.S371787.].
Progress in research of etiology and epidemiology of 2019-nCoV Omicron variant
Description
2019-nCoV Omicron variant has become predominant in the world. New subvariants with further mutations in their spike proteins are continuously emerging. Compared with the wild type and other variants of concern, Omicron variant exhibits altered
Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC
Description
Since the emergence of the Omicron variant of SARS-CoV-2, though considered less virulent, hospitalization and death rates among immunocompromised patients remain high, especially for poor responders to vaccination. We conducted a retrospective